Ebola Virus Net is the web resource for anyone interested in ebola. Ebola (Ebola hemorrhagic fever), is a severe, often fatal disease in humans and nonhuman primates such as monkeys, gorillas, and chimpanzees. Ebola is a rare and deadly disease caused by infection with a virus of the family Filoviridae, genus Ebolavirus. There are five identified Ebolavirus species, four of which have caused disease in humans. Ebola is found in several African countries. The first Ebola species was discovered in 1976 near the Ebola River in the Democratic Republic of the Congo. Since then, outbreaks have appeared sporadically in Africa. The largest outbreak to date was the epidemic in West Africa, which occurred from December 2013, to January 2016, with 28,646 cases and 11,323 deaths. Other outbreaks in Africa began in the Democratic Republic of the Congo in May 2017 and 2018. In July 2019, the World Health Organization declared the Congo Ebola outbreak a world health emergency.

When an infection does occur in humans, the virus can be spread to others through direct contact with the blood or body fluids of a person who is sick with Ebola, or through contact with objects that have been contaminated with the blood or body fluids of an infected person. Until recent, no vaccines were effective. In December 2016, Ebola was found to be 70–100% prevented by rVSV-ZEBOV vaccine, making it the first proven vaccine against the disease. More than 100,000 people have been vaccinated against Ebola as of 2019.

The objectives of Ebola Virus Net are to be the public and professional information resource for ebola and to serve as a network in the exchange of information and news related to ebola.

• Ghana declares 1st ever outbreak of Ebola-like Marburg virus disease - ABC News
  Mon, 18 Jul 2022 07:00 GMT
• Marburg virus disease outbreak: Symptoms, transmission, and more - Medical News Today
  Thu, 21 Jul 2022 07:00 GMT
• Marburg Virus: What You Should Know About This Close Cousin of Ebola - Global Citizen
  Mon, 25 Jul 2022 07:00 GMT
• Whispering gallery mode device offers rapid Ebola diagnosis – Physics World - physicsworld.com
  Thu, 21 Jul 2022 07:00 GMT
• Marburg virus outbreak: Ebola's equally dangerous cousin - USA TODAY
  Fri, 29 Jul 2022 07:00 GMT
• Mysterious Ebola-Like Disease Kills 3 In Tanzania, Probe Launched - NDTV
  Thu, 14 Jul 2022 07:00 GMT
• Ebola Virus Vaccine Market Size, Scope, Revenue, Opportunities and Growth by 2028 – Shanghaiist - Shanghaiist
  Wed, 10 Aug 2022 14:48 GMT
• How monkeypox myths mimic lies about covid and AIDS - Grid
  Mon, 08 Aug 2022 13:31 GMT
• Covid, Zika, Swine Flu, Ebola and Monkeypox: When does WHO trigger highest alert | Mint - Mint
  Sun, 24 Jul 2022 07:00 GMT
• Child dies of Marburg virus in Ebola-like disease outbreak with symptoms shared - The Mirror
  Tue, 02 Aug 2022 07:00 GMT
• 7 Times the World Health Organization Declared a Public Health Emergency (Including for Monkeypox) - Mentalfloss
  Tue, 09 Aug 2022 18:00 GMT
• Developing antivirals for pandemic-level viruses | UIC Today - UIC Today
  Mon, 08 Aug 2022 15:00 GMT
• Fauci and other health 'experts' are messing up monkeypox just as they did COVID, Ebola and AIDS - New York Post
  Thu, 04 Aug 2022 23:01 GMT
• Is monkeypox an STD? Why the answer matters for slowing New York's outbreak - Gothamist
  Tue, 09 Aug 2022 10:05 GMT
• Ebola virus disease - Democratic Republic of the Congo - World Health Organization
  Thu, 28 Apr 2022 07:00 GMT

• PRO/AH/EDR> Ebola update (44): Burkina Faso ex Cote d'Ivoire, 2nd case, NOT
  Mon, 30 Aug 2021 11:01:25 -0400
  Ebola -- Burkina Faso
  On 22 Aug 2021, the Ministry of Health informed the population of the admission to the Medical Emergencies of the Bogodogo University Hospital (CHU-B) of a 22-year-old patient who had stayed in the Republic of [Cote d'Ivoire]. The diagnostic procedure consisted of sampling analysis at the National Reference Laboratory for Viral Haemorrhagic Fever (LNR-FHV at the Muraz Centre) and the Pasteur Institute of Dakar for confirmation. The results obtained make it possible to permanently rule out

• Sexual and reproductive health services during outbreaks, epidemics, and pandemics in sub-Saharan Africa: a literature scoping review Tue, 09 Aug 2022 06:00:00 -0400
  CONCLUSION: Access to SRH services during epidemics among adolescents and young people in SSA is understudied. We found that no studies focused on SRH outcomes of abortion, emergency contraception, sexually transmitted infections, or cervical cancer. To improve access to and utilization of SRH during pandemics, we recommend the following; in terms of research, key standardized SRH indicators should be included in routine data collection, routine data should be disaggregated by age, gender, and...
• Monkeypox Epidemic: A Throwback From Smallpox Eradication Mon, 08 Aug 2022 06:00:00 -0400
  The emergence of microbial diseases has become a major concern for humans. In the recent past, we have noticed the emergence and re-emergence of several microbes that include coronaviruses (severe acute respiratory syndrome coronavirus {SARS-CoV}, Middle-East respiratory syndrome coronavirus {MERS-CoV}, SARS-CoV-2), and others like Zika virus, Nipah virus, Influenza virus, and Ebola virus. These microbes have been noted to spill over from animals into humans. Several such microbes which were...
• Next-generation sequencing for surveillance of antimicrobial resistance and pathogenicity in municipal wastewater treatment plants Fri, 05 Aug 2022 06:00:00 -0400
  The World Health Organization (WHO) ranks antimicrobial resistance (AMR) and various pathogens among the top 10 health threats. It is estimated that by 2050, the number of human deaths due to AMR will reach 10 million annually. On the other hand, several infectious outbreaks such as SARS, H1N1 influenza, Ebola, Zika fever, and COVID-19 have severely affected human populations worldwide in the last 20 years. These recent global diseases have generated the need to monitor outbreaks of pathogens...
• Glycan shield of the ebolavirus envelope glycoprotein GP Thu, 04 Aug 2022 06:00:00 -0400
  The envelope glycoprotein GP of the ebolaviruses is essential for host cell entry and the primary target of the host antibody response. GP is heavily glycosylated with up to 17 N-linked sites, numerous O-linked glycans in its disordered mucin-like domain (MLD), and three predicted C-linked mannosylation sites. Glycosylation is important for host cell attachment, GP stability and fusion activity, and shielding from neutralization by serum antibodies. Here, we use glycoproteomics to profile the...
• Monkeypox virus neurological manifestations in comparison to other orthopoxviruses Thu, 04 Aug 2022 06:00:00 -0400
  Viral infectious diseases have various neurological manifestations, whether they are epidemic or pandemic in nature. Nonspecific encephalopathy is the most common central nervous system (CNS) manifestation. The spectrum of nervous evidence varies for viral pathogens. Some infectious viruses, such as the Ebola virus, exhibit direct neurotropism. Others, such as the Rift Valley fever virus, have the potential for neurotropism. Direct neurotropism is unknown in monkeypox virus, SARS-CoV-2,...
• Balanced diet and daily calorie consumption: Consumer attitude during the COVID-19 pandemic from an emerging economy Thu, 04 Aug 2022 06:00:00 -0400
  This article tries to explore consumer attitudes regarding a balanced diet and daily calorie intake monitoring during the COVID-19 pandemic in India. It has become vital to boost people's immunity because of reoccurring diseases such as COVID-19, Ebola, and other chronic diseases such as diabetes, thyroid disease, etc. Healthy diets are important for supporting immune systems and keeping track of daily calorie consumption is an accompaniment to this. The research on attitudes toward a balanced...
• Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera Mon, 01 Aug 2022 06:00:00 -0400
  BACKGROUND: To investigate a vaccine technology with potential to protect against coronavirus disease 2019 (COVID-19) and reduce transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with a single vaccine dose, we developed a SARS-CoV-2 candidate vaccine using the live vesicular stomatitis virus (VSV) chimeric virus approach previously used to develop a licensed Ebola virus vaccine.
• Chlorine efficacy against bacteriophage Phi6, a surrogate for enveloped human viruses, on porous and non-porous surfaces at varying temperatures and humidity Mon, 01 Aug 2022 06:00:00 -0400
  While efficacy of chlorine against Phi6, a widely-used surrogate for pathogenic enveloped viruses, is well-documented, surfaces common to low-resource contexts are under-researched. We evaluated seven surfaces (stainless steel, plastic, nitrile, tarp, cloth, concrete, wood) and three environmental conditions-temperature (4, 25, 40 °C), relative humidity (RH) (23, 85%), and soiling-to determine Phi6 recoverability and the efficacy of disinfection with 0.5% NaOCl. Overall, Phi6 recovery was >4...
• Legal assessment of BIMCO's infectious or contagious diseases (IOCD) clauses for voyage and time charter parties Mon, 01 Aug 2022 06:00:00 -0400
  The impact of the Covid-19 pandemic on the shipping industry is still severe, ranging from vessels being denied entrance to ports to crews on board ships being trapped for many months. To counter and regulate those emerging issues, the shipping industry presently incorporated into the charter parties the BIMCO's Disease Clause originated from the 2015 Ebola outbreak, the so-called BIMCO's Infectious or Contagious Diseases (IOCD) Clauses. While proved successful during the Ebola outbreak, those...
• Marburg virus disease: A deadly rare virus is coming Sun, 31 Jul 2022 06:00:00 -0400
  Two cases of the deadly Marburgvirus were reported in Ghana, which might be a new global virus alert following COVID-19 and novel monkeypox. Thus far, there is no vaccine or treatment for Marburg virus disease, which is a disease with a mortality rate as high as that of Ebola. Although now human infections with Marburgvirus occurred mainly in Africa, outbreaks were twice reported in Europe over the past 55 years. A concern is that globalization might promote its global viral transmission, just...